Heraeus Medical GmbH, a leading name in the medical technology sector, is headquartered in Hanau, Germany. Established in 1851, the company has evolved into a key player in the fields of orthopaedics and trauma surgery, providing innovative solutions that enhance patient care. With a strong presence in Europe, North America, and Asia, Heraeus Medical is renowned for its advanced bone cement and biomaterials, which are distinguished by their superior quality and reliability. The company’s commitment to research and development has led to significant milestones, including the introduction of innovative products that set industry standards. Heraeus Medical's unique offerings, such as its high-performance bone cements, have positioned it as a trusted partner for healthcare professionals worldwide. With a focus on improving surgical outcomes, Heraeus Medical continues to achieve notable recognition within the medical community.
How does Heraeus Medical GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Heraeus Medical GmbH's score of 36 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Heraeus Medical GmbH reported total carbon emissions of approximately 841,000 kg CO2e, comprising 544,000 kg CO2e from Scope 1 and 297,000 kg CO2e from Scope 2. The previous year, 2023, saw total emissions of about 244,080 kg CO2e, with Scope 1 emissions at 544,000 kg CO2e, Scope 2 at 297,000 kg CO2e, and Scope 3 emissions at 22,700 kg CO2e. In 2021, the company recorded total emissions of around 1,346,000 kg CO2e, with Scope 1 emissions at 681,000 kg CO2e, Scope 2 at 1,014,000 kg CO2e, and Scope 3 at 11,660 kg CO2e. Heraeus Medical GmbH is a current subsidiary of Heraeus Holding GmbH, which influences its emissions data and climate commitments. However, there are no specific reduction targets or climate pledges disclosed at this time. The company is committed to monitoring and reporting its emissions, aligning with industry standards for transparency and accountability in climate action.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 20,488,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 40,897,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | 00,000,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Heraeus Medical GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.